| scholarly article | Q13442814 |
| P2093 | author name string | Eugenia Wang | |
| C Rick Lyons | |||
| Julie Hutt | |||
| Mary F Lipscomb | |||
| Julie Lovchik | |||
| Sara Heninger | |||
| Kristin Garrison | |||
| Lucy Berliba | |||
| P2860 | cites work | Bacillus anthracis | Q24672893 |
| Epidemiologic investigations of bioterrorism-related anthrax, New Jersey, 2001 | Q24997458 | ||
| Quantitative pathology of inhalational anthrax I: quantitative microscopic findings | Q28189054 | ||
| The Sverdlovsk anthrax outbreak of 1979 | Q28241641 | ||
| Biological warfare. A historical perspective | Q28245363 | ||
| Pathology and pathogenesis of bioterrorism-related inhalational anthrax | Q28395786 | ||
| Anthrax as a biological weapon, 2002: updated recommendations for management | Q29615587 | ||
| Anthrax | Q29620675 | ||
| Passive transfer of protection against Bacillus anthracis infection in a murine model | Q30696618 | ||
| Germination of Bacillus anthracis spores within alveolar macrophages | Q31906487 | ||
| The immune system in the elderly: II. Specific cellular immunity. | Q33784049 | ||
| Molecular pathogenesis of Bacillus anthracis infection | Q33792559 | ||
| Anthrax spores make an essential contribution to vaccine efficacy | Q34117857 | ||
| Amino acid- and purine ribonucleoside-induced germination of Bacillus anthracis DeltaSterne endospores: gerS mediates responses to aromatic ring structures | Q34305999 | ||
| Anthrax toxin | Q34398984 | ||
| Spore germination | Q34607216 | ||
| Inhalational Anthrax | Q34642223 | ||
| Bacillus anthracis genetics and virulence gene regulation | Q34840393 | ||
| Anthrax toxins and the host: a story of intimacy | Q35050924 | ||
| Protective immunity induced by Bacillus anthracis toxin-deficient strains. | Q35400677 | ||
| Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice | Q35679008 | ||
| Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. | Q36165837 | ||
| Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. | Q36976315 | ||
| Differences in susceptibility of inbred mice to Bacillus anthracis | Q37028114 | ||
| Polymorphonuclear Functions and Aging in Humans* | Q40353772 | ||
| Woolsorters' disease. An experimental model. | Q43699473 | ||
| Bacillus anthracis infection in irradiated mice: susceptibility, protection, and therapy. | Q43902081 | ||
| Germination of Bacillus cereus spores in response to L-alanine and to inosine: the roles of gerL and gerQ operons | Q44052642 | ||
| Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis). | Q44550683 | ||
| Bacterial spore germination and protein mobility | Q44616176 | ||
| Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge | Q50146700 | ||
| Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis | Q54393370 | ||
| Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes | Q54405097 | ||
| Pathology of experimental inhalation anthrax in the rhesus monkey | Q71518493 | ||
| Early Bacillus anthracis-macrophage interactions: intracellular survival survival and escape | Q73510514 | ||
| Intrapulmonary distribution of deposited particles | Q73565342 | ||
| Respiratory pathogenicity of Bacillus anthracis spores; genetic variation in respiratory pathogenicity and invasiveness of colonial variants of B. anthracis | Q83305761 | ||
| The stability of messenger ribonucleic acid during sporulation in Bacillus subtilis | Q93823976 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infectious disease | Q18123741 |
| murine model | Q122890741 | ||
| P304 | page(s) | 4801-9 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility | |
| P478 | volume | 72 |
| Q27313379 | A New Murine Model for Gastrointestinal Anthrax Infection |
| Q58105021 | A case of anthrax in two captive pumas (Puma concolor) |
| Q36122915 | Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure. |
| Q37777543 | Aerobiology and inhalation exposure to biological select agents and toxins. |
| Q35048029 | Animals devoid of pulmonary system as infection models in the study of lung bacterial pathogens |
| Q35073710 | Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival |
| Q52648908 | Avirulent Bacillus anthracis Strain with Molecular Assay Targets as Surrogate for Irradiation-Inactivated Virulent Spores |
| Q35652068 | Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax |
| Q30412775 | Bacillus anthracis Has Two Independent Bottlenecks That Are Dependent on the Portal of Entry in an Intranasal Model of Inhalational Infection |
| Q35085358 | Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice |
| Q36396810 | Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function |
| Q34721373 | Bacillus anthracis phospholipases C facilitate macrophage-associated growth and contribute to virulence in a murine model of inhalation anthrax |
| Q36895609 | Bacillus anthracis: interactions with the host and establishment of inhalational anthrax. |
| Q35139395 | Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice. |
| Q33739694 | Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax |
| Q34476038 | Cathelicidin administration protects mice from Bacillus anthracis spore challenge |
| Q47192883 | Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis |
| Q36523135 | Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia |
| Q92493311 | Choosing the right animal model for infectious disease research |
| Q36708397 | Contribution of toxins to the pathogenesis of inhalational anthrax |
| Q33230047 | Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen |
| Q28397093 | Debridement Increases Survival in a Mouse Model of Subcutaneous Anthrax |
| Q28383565 | Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging |
| Q34575393 | Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model |
| Q37033041 | Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model. |
| Q36472130 | Disrupting the luxS quorum sensing gene does not significantly affect Bacillus anthracis virulence in mice or guinea pigs. |
| Q36314045 | Effects of endogenous D-alanine synthesis and autoinhibition of Bacillus anthracis germination on in vitro and in vivo infections |
| Q92915372 | Evaluation of liposomal ciprofloxacin formulations in a murine model of anthrax |
| Q28396400 | Exogenous interferon-alpha and interferon-gamma increase lethality of murine inhalational anthrax |
| Q36155940 | Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax |
| Q35688979 | Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis |
| Q28385270 | Histopathology in a murine model of anthrax |
| Q24555744 | Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences |
| Q34334451 | Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax |
| Q53530861 | Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis |
| Q28392659 | Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames |
| Q35806278 | Impact of Spores on the Comparative Efficacies of Five Antibiotics for Treatment of Bacillus anthracis in an In Vitro Hollow Fiber Pharmacodynamic Model |
| Q36845180 | In vivo demonstration and quantification of intracellular Bacillus anthracis in lung epithelial cells |
| Q33576071 | In vivo efficacy of a phosphodiester TLR-9 aptamer and its beneficial effect in a pulmonary anthrax infection model |
| Q42288495 | In vivo murine and in vitro M-like cell models of gastrointestinal anthrax |
| Q42924668 | Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax |
| Q28387410 | Inhalational anthrax (Ames aerosol) in naïve and vaccinated New Zealand rabbits: characterizing the spread of bacteria from lung deposition to bacteremia |
| Q46860908 | Inhibition of mitogen-activated protein kinase signalling by Bacillus anthracis lethal toxin causes destabilization of interleukin-8 mRNA. |
| Q34471098 | Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection |
| Q27312575 | Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection |
| Q33768818 | Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A |
| Q57283998 | Low translocation ofBacillus thuringiensisisraelensisto inner organs in mice after pulmonary exposure to commercial biopesticide |
| Q39369936 | Lung B cells promote early pathogen dissemination and hasten death from inhalation anthrax |
| Q38324596 | Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores |
| Q33264045 | Morphogenesis of the Bacillus anthracis spore |
| Q35139371 | Multigenic control and sex bias in host susceptibility to spore-induced pulmonary anthrax in mice |
| Q35913511 | Murine aerosol challenge model of anthrax |
| Q35783849 | Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains |
| Q30841127 | Nucleotide biosynthesis is critical for growth of bacteria in human blood |
| Q28392599 | Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax |
| Q79765863 | Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization |
| Q37775428 | Pathology of inhalational anthrax animal models |
| Q36901955 | Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism |
| Q34490786 | Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule |
| Q33286415 | Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax |
| Q34368520 | Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis |
| Q33261310 | Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsule |
| Q33917975 | Pulmonary responses to Stachybotrys chartarum and its toxins: mouse strain affects clearance and macrophage cytotoxicity |
| Q37341111 | Rapid detection of the poly-gamma-D-glutamic acid capsular antigen of Bacillus anthracis by latex agglutination |
| Q44574630 | Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge |
| Q30859046 | Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis |
| Q33586051 | Regulatory interactions of a virulence-associated serine/threonine phosphatase-kinase pair in Bacillus anthracis |
| Q33735602 | Role of Purine Biosynthesis in Bacillus anthracis Pathogenesis and Virulence |
| Q34301043 | Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection |
| Q35221982 | Sepsis and pathophysiology of anthrax in a nonhuman primate model |
| Q55361721 | Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia |
| Q43097078 | TLR sensing of bacterial spore-associated RNA triggers host immune responses with detrimental effects. |
| Q28390216 | The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages |
| Q37075377 | The Bacillus anthracis protein MprF is required for synthesis of lysylphosphatidylglycerols and for resistance to cationic antimicrobial peptides |
| Q89698047 | The Impact of Age and Sex on Mouse Models of Melioidosis |
| Q37060218 | The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax |
| Q35217494 | Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax |
| Q30440528 | Transcriptional and apoptotic responses of THP-1 cells to challenge with toxigenic, and non-toxigenic Bacillus anthracis |
| Q35913562 | Transcriptional profiling of Bacillus anthracis during infection of host macrophages |
| Q36692504 | Transcriptional profiling of murine organ genes in response to infection with Bacillus anthracis Ames spores |
| Q49488340 | Tuberculosis in the elderly: Why inflammation matters |
| Q36646601 | Vaccine Protection against Bacillus cereus-Mediated Respiratory Anthrax-Like Disease in Mice |
Search more.